Kinetics and Thermodynamics of Fibril Elongation and Dissociation of Dual Glucagon-like Peptide and Glucagon Receptor Agonists
- 4 August 2026
- journal article
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 42 (32) , 23398-23415
Abstract
Obesity and type 2 diabetes require durable peptide therapeutics, yet oxyntomodulin (Oxm) and its analogue Aib2-Oxm exhibit short serum half-lives due to rapid enzymatic degradation. Fibrillar self-assembly markedly enhances their stability, motivating a systematic understanding of the thermodynamics and kinetics governing fibril formation and dissociation. Here, using quartz crystal microbalance with dissipation (QCM-D), we provide the first comprehensive quantitative analysis of these processes for Oxm and Aib2-Oxm. Both peptides form fibrils under the experimental conditions studied, with equilibrium free-peptide concentrations indicating that fibril incorporation is thermodynamically favored when soluble peptide concentration exceeds the equilibrium solubility. Oxm fibrils exhibit greater apparent thermodynamic stability than Aib2-Oxm fibrils, consistent with lower equilibrium free-peptide concentration, greater apparent lateral fibril association, and secondary-structure trends. Oxm peptides also exhibit faster elongation on preformed fibril seeds, whereas Aib2-Oxm fibril elongation is associated with a larger apparent activation barrier for conformational incorporation into the fibrillar state. Oxm peptides also nucleate and elongate more rapidly, whereas Aib2-Oxm fibrillation is slowed by a larger activation energy for peptide unfolding. Consequently, Aib2-Oxm fibrils dissociate faster than Oxm fibrils, predicting greater in-serum bioactivity due to enhanced peptide release. To enable controlled therapeutic deployment, we examined Aib2-Oxm fibrillation and dissociation across temperature, peptide concentration, and seed size. Aib2-Oxm assembly follows classical Arrhenius behavior, with fibrillation rates doubling between 23 and 37 °C. Peptide release likewise increases with temperature and is substantially slower at subcutaneous conditions (32 °C) than at core physiological temperatures (37–42 °C), supporting prolonged bioactive release following subcutaneous administration. This work provides the first integrated thermodynamic–kinetic framework for Oxm and Aib2-Oxm fibrils and establishes principles for engineering long-acting, protease-resistant peptide depots for obesity and type 2 diabetes therapy.Keywords
Funding Information
- Graduate Program in Physics at UNIFAL-MG (NA)
- Graduate Program in Physics at UNIFAL-MG (NA)
This publication has 35 references indexed in Scilit:
- Thermo-Responsive self-assembly of a dual glucagon-like peptide and glucagon receptor agonistInternational Journal of Pharmaceutics, 2021
- The Epidemiology of Obesity: A Big PicturePharmacoEconomics, 2014
- The forgotten members of the glucagon familyDiabetes Research and Clinical Practice, 2014
- Action and therapeutic potential of oxyntomodulinMolecular Metabolism, 2014
- Gut hormones as therapeutic agents in treatment of diabetes and obesityCurrent Opinion in Pharmacology, 2013
- Electrostatic Effects in Filamentous Protein AggregationBiophysical Journal, 2013
- Detailed Analysis of the Energy Barriers for Amyloid Fibril GrowthAngewandte Chemie International Edition, 2012
- The mechanism of amyloid‐fibril formation by stefin B: Temperature and protein concentration dependence of the ratesProteins: Structure, Function, and Bioinformatics, 2008
- Protein secondary structure analyses from circular dichroism spectroscopy: Methods and reference databasesBiopolymers, 2007
- Estimation of Protein Secondary Structure from Circular Dichroism Spectra: Comparison of CONTIN, SELCON, and CDSSTR Methods with an Expanded Reference SetAnalytical Biochemistry, 2000